26438070|t|Acute liver failure and seizures as a consequence of regorafenib exposure in advanced rectal cancer.
26438070|a|BACKGROUND: Regorafenib is a multi-targeted tyrosine kinase inhibitor approved for use in refractory colorectal cancer. We report the first case of seizures secondary to acute liver failure, shortly after initiation of regorafenib in a patient with advanced rectal carcinoma. CASE PRESENTATION: A 64 year-old Caucasian female presented with confusion and generalized tonic-clonic seizures, 5 days after initiation of regorafenib for advanced rectal cancer. Investigations revealed significant elevations in bilirubin and alanine aminotransferase. No other cause for seizures and liver dysfunction were found. After interruption of regorafenib, no further seizures occurred, the symptoms of confusion resolved and liver function returned to normal. CONCLUSIONS: We report the first case of regorafenib-induced acute liver failure resulting in seizures. We suggest early monitoring for side effects, both clinically and biochemically after initiation of regorafenib.
26438070	0	19	Acute liver failure	Disease	MESH:D017114
26438070	24	32	seizures	Disease	MESH:D012640
26438070	53	64	regorafenib	Chemical	MESH:C559147
26438070	86	99	rectal cancer	Disease	MESH:D012004
26438070	113	124	Regorafenib	Chemical	MESH:C559147
26438070	145	160	tyrosine kinase	Gene	7294
26438070	202	219	colorectal cancer	Disease	MESH:D015179
26438070	249	257	seizures	Disease	MESH:D012640
26438070	271	290	acute liver failure	Disease	MESH:D017114
26438070	320	331	regorafenib	Chemical	MESH:C559147
26438070	337	344	patient	Species	9606
26438070	359	375	rectal carcinoma	Disease	MESH:D012004
26438070	468	489	tonic-clonic seizures	Disease	MESH:D012640
26438070	518	529	regorafenib	Chemical	MESH:C559147
26438070	543	556	rectal cancer	Disease	MESH:D012004
26438070	608	617	bilirubin	Chemical	MESH:D001663
26438070	667	675	seizures	Disease	MESH:D012640
26438070	680	697	liver dysfunction	Disease	MESH:D017093
26438070	732	743	regorafenib	Chemical	MESH:C559147
26438070	756	764	seizures	Disease	MESH:D012640
26438070	890	901	regorafenib	Chemical	MESH:C559147
26438070	910	929	acute liver failure	Disease	MESH:D017114
26438070	943	951	seizures	Disease	MESH:D012640
26438070	1053	1064	regorafenib	Chemical	MESH:C559147
26438070	Negative_Correlation	MESH:C559147	7294
26438070	Negative_Correlation	MESH:C559147	MESH:D015179
26438070	Positive_Correlation	MESH:C559147	MESH:D012640
26438070	Negative_Correlation	MESH:C559147	MESH:D012004
26438070	Positive_Correlation	MESH:C559147	MESH:D017114

